Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Maintains Outperform on NexImmune, Lowers Price Target to $3

Raymond James analyst Steven Seedhouse maintains NexImmune (NASDAQ:NEXI) with a Outperform and lowers the price target from $12 to $3.
byBenzinga Newsdesk
August 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Raymond James analyst Steven Seedhouse maintains NexImmune (NASDAQ:NEXI) with a Outperform and lowers the price target from $12 to $3.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Transocean Stock Traded Lower On Monday: What Happened?

By Vaishali Prayag
June 3, 6:12 PM
Shares of Transocean LTD (NYSE: RIG) traded lower on Monday following an OPEC+ decision to extend deep oil output cuts until 2025. The Organization of the Petroleum Exporting Countries and allies led by Russia, known as OPEC+, aims to address concerns over tepid demand growth, high interest rates and rising U.S. production.

RIG